Table of Contents

Table of Contents

CareSource Pharmacy Policy Statement Marketplace Table of Contents Amevive (alefacept) ............................................................................................................................................................... 4 Antihemophilic Agents (Advate, Adynovate, Afstyla, Alphanate, Alphanate/VWF Complex/Human, AlphaNine SD, Alprolix, Bebulin, Bebulin VH, BeneFIX, Coagadex, Corifact, Eloctate, Esperoct, Factor VIII SD (Human), Feiba, Feiba NF, Feiba VH Immuno, Fibryga, Helixate, Helixate FS, Hemlibra, Hemofil M, Humate-P, Humate-P Human, Idelvion, Ixinity, Jivi, Kcentra, Koate, Koate-DVI, Koate-HP, Kogenate, Kogenate FS, Kogenate FS Bio-Set, Kovaltry, Monoclate-P, Mononine, Novoeight, NovoSeven RT, Nuwiq, Obizur, Profilnine, Profilnine SD, Rebinyn, Recombinate, RiaSTAP, Rixubis, Tretten, Vonvendi, Wilate, Xyntha, and Xyntha Solofuse) ........................................................................................ 7 Benlysta (belimumab) .......................................................................................................................................................... 11 Berinert (C1 esterase inhibitor [human]) .............................................................................................................................. 13 Boniva (ibandronate) ............................................................................................................................................................ 15 Botox (onabotulinumtoxinA) ................................................................................................................................................. 17 Brineura (cerliponase alfa) ................................................................................................................................................... 24 Cinryze (C1 esterase inhibitor [human]) ............................................................................................................................... 26 Crysvita (burosumab-twza) .................................................................................................................................................. 28 Durolane (sodium hyaluronate) ............................................................................................................................................ 31 Dysport (abobotulinumtoxinA).............................................................................................................................................. 33 Entyvio (vedolizumab) .......................................................................................................................................................... 36 Epogen (epoetin alfa) ........................................................................................................................................................... 39 Euflexxa (sodium hyaluronate)............................................................................................................................................. 42 Evenity (romosozumab-aggg) .............................................................................................................................................. 45 Exondys 51 (eteplirden) ....................................................................................................................................................... 47 Fasenra (benralizumab) ....................................................................................................................................................... 49 Firazyr (icatibant) .................................................................................................................................................................. 51 Fulphila (pegfilgrastim-jmdb) ................................................................................................................................................ 53 Gamifant (emapalumab-lzsg) ............................................................................................................................................... 58 Gel-One (sodium hyaluronate) ............................................................................................................................................. 60 Gelsyn-3 (sodium hyaluronate) ............................................................................................................................................ 63 GenVisc 850 (sodium hyaluronate) ...................................................................................................................................... 65 Granix (tbo-filgrastim) ........................................................................................................................................................... 67 1 CareSource Pharmacy Policy Statement Marketplace H.P Acthar Gel (respiratory corticotropin injection) .............................................................................................................. 69 Haegarda (C1 inhibitor(human)] ........................................................................................................................................... 71 Hyalgan (sodium hyaluronate) ............................................................................................................................................. 73 Hymovis (sodium hyaluronate) ............................................................................................................................................ 75 Ilumya (tildrakizumab-asmn) ................................................................................................................................................ 77 Immune Globulin (Intravenous[IVIG]) ................................................................................................................................. 80 Intravenous: Bivigam, Carimune NF, Flebogamma DIF, Gammagard Liquid, Gammagard S/D, Gammaked,Gammaplex, Gamunex-C, Octagam, Privigen, and Thymoglobulin Subcutaneous: Cuvitru, Hizentra, HyQvia and Xembify Inflectra (infliximab-dyyb) ..................................................................................................................................................... 92 Kalbitor (ecallantide) ............................................................................................................................................................ 99 Kanuma (sebelipase alfa) ................................................................................................................................................... 101 Kymriah (tisangenlecleucel) ............................................................................................................................................... 103 Lemtrada (alemtuzumab) ................................................................................................................................................... 106 Lupron (leuprolide acetate) ................................................................................................................................................ 108 Luxturna (voretigene neparvovec-rzyl) .............................................................................................................................. 113 Makena (hydroxyprogesterone caproate) ........................................................................................................................... 115 Mepsevii (vestronidase alfa-vjbk) ....................................................................................................................................... 117 Monovisc (sodium hyaluronate) ......................................................................................................................................... 119 Myobloc (rimabotulinumtoxinB) .......................................................................................................................................... 121 Novantrone (mitoxantrone) ................................................................................................................................................ 124 NPlate (romiplostim) ........................................................................................................................................................... 126 Ocrevus (ocrelizumab) ....................................................................................................................................................... 128 Onpattro (patisiran) ............................................................................................................................................................ 131 Orencia (abatacept) ............................................................................................................................................................ 133 Orthovisc (sodium hyaluronate)......................................................................................................................................... 137 Procrit (epoetin alfa) ........................................................................................................................................................... 139 Prolia (denosumab) ............................................................................................................................................................ 142 Radicava (edaravone injection) .........................................................................................................................................

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    218 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us